Caribou Biosciences is a clinical-stage biopharmaceutical company specializing in CRISPR genome-editing technology. We focus on developing next-generation, off-the-shelf cell therapies designed to effectively treat serious diseases like hematologic malignancies and autoimmune disorders. Our innovative approach to genome editing sets us apart in the biotechnology space, aiming to provide transformative therapies to patients in need.
No jobs found. Subscribe below to get notified when we find something for you.
Searching